top of page

Enjoy Eating Healthy by Trusting Your Gut Feeling
All Posts


GLP-1 Drugs and Long-Term Safety: Side Effects, Muscle Loss, Tapering and Preventive Use
In recent years, GLP-1 receptor agonist medications such as Semaglutide and Tirzepatide have revolutionised the treatment of obesity and type 2 diabetes. Beyond improving glycemic control, these drugs induce significant weight loss by reducing appetite, slowing gastric emptying, and improving insulin sensitivity. However, while their effectiveness is well documented, the implications of long-term use deserve deeper consideration . In this article, we explore four aspects that
Claudia Gravaghi


GLP-1 Anti-Obesity Drugs and Addiction: What New Research Is Revealing
In recent years, drugs acting on the GLP-1 system have become central to the treatment of obesity. Originally developed for diabetes, these medications (e.g., Wegovy and Mounjaro) have demonstrated remarkable efficacy in controlling appetite and promoting weight loss. Today, however, research is suggesting something even more intriguing: these drugs might also play a role in reducing the risk of addiction. A recent article published in Nature highlights findings from a larg
Claudia Gravaghi


From “Type 3 Diabetes” to Incretin Therapies: Can GLP-1 Drugs Modify Alzheimer’s Disease Progression?
GLP-1 and Alzheimer's Disease: The Metabolic Hypothesis of Type 3 Diabetes For many years, Alzheimer’s disease was explained almost exclusively in terms of beta-amyloid plaque accumulation and tau protein tangles. Over the past two decades, however, metabolic research has shifted part of the focus toward another mechanism: impaired insulin signalling in the brain. In 2008, de la Monte and Wands introduced the concept of “type 3 diabetes,” observing that Alzheimer’s brains sh
Claudia Gravaghi


The Future of GLP-1 Receptor Drugs: Oral GLP-1 and New Trends by 2028
The landscape of GLP-1 (Glucagon-Like Peptide-1) receptor agonists is evolving at a breakneck pace. Originally developed for Type 2 diabetes , these drugs have reshaped metabolic medicine and are now at the forefront of obesity, cardiometabolic, and broader therapeutic research . Over the next two years (2026–2028) , we expect dramatic innovation that will redefine how we treat metabolic health. New Drug Modalities & Approvals Oral GLP-1 Receptor Drugs Future— Game Changers
Claudia Gravaghi


Why do some people not lose weight on semaglutide?
A new study published in Nature analysed nearly 28,000 individuals to understand why responses to GLP-1 drugs such as semaglutide vary so widely. Some people lose a significant amount of weight. Others lose very little. Some stop treatment due to side effects. So the question is: why does this happen? Why responses to GLP-1 drugs vary Medications such as tirzepatide act on: appetite blood glucose satiety signals brain pathways (including reward and “food noise”) Yet the resp
Claudia Gravaghi


Why Willpower Is Not the Problem in Emotional Eating
Many people who struggle with emotional eating believe they simply lack willpower. They tell themselves they should be “stronger,” more disciplined, or better at controlling food. This belief is not only inaccurate, but it’s also harmful. Emotional eating is not a failure of willpower. It is a learned, adaptive response to emotions, stress, and unmet needs. Understanding this is a crucial step toward building a healthier relationship with food. Where the Willpower Myth Comes
Claudia Gravaghi


Transforming Your Relationship with Food: The Role of GLP-1 Medications
Understanding GLP-1 Medications and Their Impact Negli ultimi anni, i farmaci GLP-1 (receptor agonists) come Ozempic, Wegovy e Mounjaro hanno trasformato il panorama della gestione del peso. Per molte persone, questi farmaci sono stati rivoluzionari, aiutandole a ridurre il cosiddetto "food noise", a perdere peso e riprendere il controllo della propria salute in modi che forse non avrebbero mai pensato possibili. Ma sebbene i GLP-1 siano potenti strumenti, non sono bacchette
Claudia Gravaghi


Master Mindful Eating to Overcome Emotional Triggers
Emotional eating can feel like a relentless cycle. You know the drill - stress hits, and suddenly, the fridge or the snack cupboard calls your name louder than your reason. I’ve been there, and I understand how tough it is to break free from that pattern. But what if I told you there’s a way to regain control, to listen to your body and mind in harmony? That’s where mindful eating comes in. It’s not just about what you eat but how you eat, and it can transform your relationsh
Claudia Gravaghi


The Importance of Nutritional and Emotional Counselling for GLP-1 Users
Over the past few years, GLP-1 medications like Ozempic , Wegovy , and Mounjaro have changed the landscape of weight management. For many people, these medications have been life-changing—helping them reduce cravings, lose weight, and gain control over their health in ways they may never have thought possible. But while GLP-1s are powerful tools, they’re not magic wands. The real transformation happens when the medication is combined with the right nutritional and emotional
Claudia Gravaghi


Unlock Sustainable Health Benefits with a London/Milan Emotional Nutritionist
When it comes to improving your health, diet plays a crucial role. But with so much conflicting information out there, where do you start? That’s where professional guidance from a nutritionist can make all the difference. I’ve personally seen how tailored advice can transform not just eating habits but overall wellbeing. If you’re struggling with emotional eating, weight management, or specific health conditions, understanding the benefits of a nutritionist and counsellor in
Claudia Gravaghi


How to starve Cancer?
My thoughts on Jane McLelland's Book "How To Starve Cancer" about the Metabolic Theory of Cancer. Welcome to THE SMART BELLY Blog Enjoy...

Claudia Gravaghi


È possibile rallentare l’invecchiamento biologico?
Welcome to THE SMART BELLY Blog Enjoy eating healthy by trusting your gut feeling Un blog un po' insolito e per la prima volta in...

Claudia Gravaghi
bottom of page
